Sample Request

COVID-19 Outbreak-Global Hospital-acquired Infections (HAIs) Control Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

SELECT LICENSE:

Published on 01/26/2021| Code: MAR41115D| Category: Utilities| Total Pages: 117

The Hospital-acquired Infections (HAIs) Control market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Hospital-acquired Infections (HAIs) Control industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Hospital-acquired Infections (HAIs) Control market can be split based on product types, major applications, and important countries as follows:

Key players in the global Hospital-acquired Infections (HAIs) Control market covered in Chapter 12:

STERIS Corporation
Advanced Sterilization Products Division
Becton Dickinson
Hoffmann-La Roche
Pfizer

In Chapter 4 and 14.1, on the basis of types, the Hospital-acquired Infections (HAIs) Control market from 2015 to 2025 is primarily split into:

Diagnostic Techniques
Dleaning and Sterilization
Treatment

In Chapter 5 and 14.2, on the basis of applications, the Hospital-acquired Infections (HAIs) Control market from 2015 to 2025 covers:

General Hospital
Infectious Disease Hospital

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)

United States

Canada

Mexico

Europe (Covered in Chapter 8 and 14)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 9 and 14)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 10 and 14)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 11 and 14)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 Hospital-acquired Infections (HAIs) Control Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Hospital-acquired Infections (HAIs) Control

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Hospital-acquired Infections (HAIs) Control industry

1.4 Methodology of The Study

1.5 Research Data Source

2 Executive Summary

2.1 Market Overview

2.1.1 Global Hospital-acquired Infections (HAIs) Control Market Size, 2015 – 2020

2.1.2 Global Hospital-acquired Infections (HAIs) Control Market Size by Type, 2015 – 2020

2.1.3 Global Hospital-acquired Infections (HAIs) Control Market Size by Application, 2015 – 2020

2.1.4 Global Hospital-acquired Infections (HAIs) Control Market Size by Region, 2015 - 2025

2.2 Business Environment Analysis

2.2.1 Global COVID-19 Status and Economic Overview

2.2.2 Influence of COVID-19 Outbreak on Hospital-acquired Infections (HAIs) Control Industry Development

3 Industry Chain Analysis

3.1 Upstream Raw Material Suppliers of Hospital-acquired Infections (HAIs) Control Analysis

3.2 Major Players of Hospital-acquired Infections (HAIs) Control

3.3 Hospital-acquired Infections (HAIs) Control Manufacturing Cost Structure Analysis

3.3.1 Production Process Analysis

3.3.2 Manufacturing Cost Structure of Hospital-acquired Infections (HAIs) Control

3.3.3 Labor Cost of Hospital-acquired Infections (HAIs) Control

3.4 Market Distributors of Hospital-acquired Infections (HAIs) Control

3.5 Major Downstream Buyers of Hospital-acquired Infections (HAIs) Control Analysis

3.6 The Impact of Covid-19 From the Perspective of Industry Chain

3.7 Regional Import and Export Controls Will Exist for a Long Time

3.8 Continued downward PMI Spreads Globally

4 Global Hospital-acquired Infections (HAIs) Control Market, by Type

4.1 Global Hospital-acquired Infections (HAIs) Control Value and Market Share by Type (2015-2020)

4.2 Global Hospital-acquired Infections (HAIs) Control Production and Market Share by Type (2015-2020)

4.3 Global Hospital-acquired Infections (HAIs) Control Value and Growth Rate by Type (2015-2020)

4.3.1 Global Hospital-acquired Infections (HAIs) Control Value and Growth Rate of Diagnostic Techniques
4.3.2 Global Hospital-acquired Infections (HAIs) Control Value and Growth Rate of Dleaning and Sterilization
4.3.3 Global Hospital-acquired Infections (HAIs) Control Value and Growth Rate of Treatment
4.4 Global Hospital-acquired Infections (HAIs) Control Price Analysis by Type (2015-2020)

5 Hospital-acquired Infections (HAIs) Control Market, by Application

5.1 Downstream Market Overview

5.2 Global Hospital-acquired Infections (HAIs) Control Consumption and Market Share by Application (2015-2020)

5.3 Global Hospital-acquired Infections (HAIs) Control Consumption and Growth Rate by Application (2015-2020)

5.3.1 Global Hospital-acquired Infections (HAIs) Control Consumption and Growth Rate of General Hospital (2015-2020)
5.3.2 Global Hospital-acquired Infections (HAIs) Control Consumption and Growth Rate of Infectious Disease Hospital (2015-2020)

6 Global Hospital-acquired Infections (HAIs) Control Market Analysis by Regions

6.1 Global Hospital-acquired Infections (HAIs) Control Sales, Revenue and Market Share by Regions

6.1.1 Global Hospital-acquired Infections (HAIs) Control Sales by Regions (2015-2020)

6.1.2 Global Hospital-acquired Infections (HAIs) Control Revenue by Regions (2015-2020)

6.2 North America Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

6.3 Europe Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

6.4 Asia-Pacific Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

6.5 Middle East and Africa Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

6.6 South America Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

7 North America Hospital-acquired Infections (HAIs) Control Market Analysis by Countries

7.1 The Influence of COVID-19 on North America Market

7.2 North America Hospital-acquired Infections (HAIs) Control Sales, Revenue and Market Share by Countries

7.2.1 North America Hospital-acquired Infections (HAIs) Control Sales by Countries (2015-2020)

7.2.2 North America Hospital-acquired Infections (HAIs) Control Revenue by Countries (2015-2020)

7.3 United States Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

7.4 Canada Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

7.5 Mexico Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

8 Europe Hospital-acquired Infections (HAIs) Control Market Analysis by Countries

8.1 The Influence of COVID-19 on Europe Market

8.2 Europe Hospital-acquired Infections (HAIs) Control Sales, Revenue and Market Share by Countries

8.2.1 Europe Hospital-acquired Infections (HAIs) Control Sales by Countries (2015-2020)

8.2.2 Europe Hospital-acquired Infections (HAIs) Control Revenue by Countries (2015-2020)

8.3 Germany Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

8.4 UK Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

8.5 France Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

8.6 Italy Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

8.7 Spain Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

8.8 Russia Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

9 Asia Pacific Hospital-acquired Infections (HAIs) Control Market Analysis by Countries

9.1 The Influence of COVID-19 on Asia Pacific Market

9.2 Asia Pacific Hospital-acquired Infections (HAIs) Control Sales, Revenue and Market Share by Countries

9.2.1 Asia Pacific Hospital-acquired Infections (HAIs) Control Sales by Countries (2015-2020)

9.2.2 Asia Pacific Hospital-acquired Infections (HAIs) Control Revenue by Countries (2015-2020)

9.3 China Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

9.4 Japan Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

9.5 South Korea Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

9.6 India Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

9.7 Southeast Asia Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

9.8 Australia Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

10 Middle East and Africa Hospital-acquired Infections (HAIs) Control Market Analysis by Countries

10.1 The Influence of COVID-19 on Middle East and Africa Market

10.2 Middle East and Africa Hospital-acquired Infections (HAIs) Control Sales, Revenue and Market Share by Countries

10.2.1 Middle East and Africa Hospital-acquired Infections (HAIs) Control Sales by Countries (2015-2020)

10.2.2 Middle East and Africa Hospital-acquired Infections (HAIs) Control Revenue by Countries (2015-2020)

10.3 Saudi Arabia Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

10.4 UAE Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

10.5 Egypt Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

10.6 Nigeria Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

10.7 South Africa Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

11 South America Hospital-acquired Infections (HAIs) Control Market Analysis by Countries

11.1 The Influence of COVID-19 on Middle East and Africa Market

11.2 South America Hospital-acquired Infections (HAIs) Control Sales, Revenue and Market Share by Countries

11.2.1 South America Hospital-acquired Infections (HAIs) Control Sales by Countries (2015-2020)

11.2.2 South America Hospital-acquired Infections (HAIs) Control Revenue by Countries (2015-2020)

11.3 Brazil Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

11.4 Argentina Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

11.5 Columbia Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

11.6 Chile Hospital-acquired Infections (HAIs) Control Sales and Growth Rate (2015-2020)

12 Competitive Landscape

12.1 STERIS Corporation
12.1.1 STERIS Corporation Basic Information
12.1.2 Hospital-acquired Infections (HAIs) Control Product Introduction
12.1.3 STERIS Corporation Production, Value, Price, Gross Margin 2015-2020
12.2 Advanced Sterilization Products Division
12.2.1 Advanced Sterilization Products Division Basic Information
12.2.2 Hospital-acquired Infections (HAIs) Control Product Introduction
12.2.3 Advanced Sterilization Products Division Production, Value, Price, Gross Margin 2015-2020
12.3 Becton Dickinson
12.3.1 Becton Dickinson Basic Information
12.3.2 Hospital-acquired Infections (HAIs) Control Product Introduction
12.3.3 Becton Dickinson Production, Value, Price, Gross Margin 2015-2020
12.4 Hoffmann-La Roche
12.4.1 Hoffmann-La Roche Basic Information
12.4.2 Hospital-acquired Infections (HAIs) Control Product Introduction
12.4.3 Hoffmann-La Roche Production, Value, Price, Gross Margin 2015-2020
12.5 Pfizer
12.5.1 Pfizer Basic Information
12.5.2 Hospital-acquired Infections (HAIs) Control Product Introduction
12.5.3 Pfizer Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook

13.1 Market Driver Analysis

13.1.2 Market Restraints Analysis

13.1.3 Market Trends Analysis

13.2 Merger, Acquisition and New Investment

13.3 News of Product Release

14 Global Hospital-acquired Infections (HAIs) Control Market Forecast

14.1 Global Hospital-acquired Infections (HAIs) Control Market Value & Volume Forecast, by Type (2020-2025)

14.1.1 Diagnostic Techniques Market Value and Volume Forecast (2020-2025)
14.1.2 Dleaning and Sterilization Market Value and Volume Forecast (2020-2025)
14.1.3 Treatment Market Value and Volume Forecast (2020-2025)
14.2 Global Hospital-acquired Infections (HAIs) Control Market Value & Volume Forecast, by Application (2020-2025)

14.2.1 General Hospital Market Value and Volume Forecast (2020-2025)
14.2.2 Infectious Disease Hospital Market Value and Volume Forecast (2020-2025)
14.3 Hospital-acquired Infections (HAIs) Control Market Analysis and Forecast by Region

14.3.1 North America Market Value and Consumption Forecast (2020-2025)

14.3.2 Europe Market Value and Consumption Forecast (2020-2025)

14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)

14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)

14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis

15.1 Industry Barriers and New Entrants SWOT Analysis

15.1.1 Porter’s Five Forces Analysis

15.1.2 New Entrants SWOT Analysis

15.2 Analysis and Suggestions on New Project Investment

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology
Mizuno Corp
AutoX
A.JAFFE
Aaga Marketing
AGRIC SA
Alcimed
AMSEC
Aquanova
AYTB Industrial
Bain & Company
Brooks Life Sciences
Cirona Labs
CMV Informatics
CONNEMARAORGANIC SEAWEED COMPANY
Desmet Ballestra Group
Dine4Fit, a.s.
Dream Incubator Vietnam Joint Stock Company
DSM
Eastman Chemical
Edwards Vacuum
Emerson
Getinge
Hello Flexibles
Industrie Beteiligungs Gesellschaft IBG
Inscripta, Inc.
JLL Technologies
Kari-Out
Marafie Engineering Co
Monitor Deloitte
Mossif3
mpumalanga stainless initiative
Nextteq, LLC
Pattern
Phizzle
Phronesis Partners Pte. Ltd.
PSP Specialties
Reno Refractories, Inc.
Roche Diagnostics International Ltd.
Rockfield Medical Device
RSG Media
Sealed Air
Sutton Capital Partners, Inc
Tenshi LifeCare Pvt Ltd (Velbiom Probiotics PVt Ltd)
The Crocodile Integrated Marketing Ltd
Tomorrow.io
UL
Vibrant Marketing
Wild Republic
ams OSRAM
Atelerix Life Sciences Inc
Beckman Coulter Life Sciences
BIOTECH VISION CARE PVT. LTD
Chiripal
Circle NVI
Freudenberg Filtration Technologies SE & Co. KG
FTA HSRP Solutions Pvt Ltd
Goetz Partners
Good clean love
Hasso Plattner d-school at UCT
InnoFaith Beauty Sciences
INSALA
Kukuza Consulting
MilliporeSigma
Panasonic Industry Europe
Quintus Technologies
Renesas
Roche Diagnostics International Ltd.
Timee, Inc.
YCP Solidiance
Graffer
Magnus
Pantex Ennerflo
The Japan Association of Bonded Magnetic Materials
SIS
Elian
RS Connect
3 Hunters Talent Solutions LATAM
Atelerix Life Sciences Inc
David Clark
DSGLOBAL CO.,LTD.
Hitotsubashi University
kovis-group
Saunacore
Suez Consulting
WestRock

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005